Jason Fleming, M.D., FACS

Dr. Fleming is chair and senior member of the Department of Gastrointestinal Oncology and surgeon specializing in pancreatic cancer at Moffitt Cancer Center. He formerly served as Director of the Tissue Acquisition and Biorepository Core for the Pancreas Cancer Research Program and initiated the first direct xenograft program in GI cancer at The University of Texas MD Anderson Cancer Center. The xenografts are derived from human pancreatic adenocarcinomas. Direct xenografts recapitulate the tumor microenvironment and provide a unique platform to examine pancreatic adenocarcinoma.